H.R. 6091 amends the statutory text that currently undergirds 42 U.S.C. §1983 to cover violations committed “under color” of federal authority as well as state authority. Practically, the bill makes the causes of action and remedial framework that courts apply in state‑actor §1983 suits available against persons acting under the authority of the United States.
The change is compact — a three‑word insertion in the statute — but consequential. By authorizing a statutory damages remedy for federal actors, the bill reconfigures the landscape that courts have filled with the judge‑made Bivens doctrine, with likely downstream effects on litigation volume, attorney‑fee exposure, and how courts treat immunity, choice‑of‑law, and remedies in claims against federal personnel.
At a Glance
What It Does
The bill inserts the words “of the United States or” into the opening clause of the Revised Statutes section now codified at 42 U.S.C. §1983, expanding the statute’s reach so that persons acting “under color” of federal law can be sued for deprivation of federal rights. It does not otherwise change standards for liability, damages, or defenses in the statute’s text.
Who It Affects
Federal law enforcement and corrections personnel (FBI, DEA, DHS/ICE, U.S. Marshals, federal prisons), federal regulatory officers acting in enforcement roles, the Department of Justice (in its defense and indemnification role), and individuals alleging constitutional and federal statutory deprivations by federal actors.
Why It Matters
Congress would be creating — by statute rather than judicial implication — a private right of action against persons exercising federal authority. That shifts debates that courts have litigated for decades (the scope of Bivens, remedial limits, immunity doctrines) into a statutory context that triggers fee‑shifting, state‑borrowed procedural rules, and new strategic litigation choices.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
Today’s §1983 litigation framework lets plaintiffs sue persons who, while acting “under color” of state law, violate rights secured by federal law or the Constitution. For federal actors, courts instead have relied on Bivens, a judge‑created damages remedy whose scope the Supreme Court has narrowed in recent years.
H.R. 6091 changes only the statutory text: it inserts “of the United States or” into the opening clause of the statute so that the same statutory cause of action applies to persons acting under federal authority.
That textual change imports a suite of practical consequences without expressly addressing them. Plaintiffs would bring claims against federal officers in their individual capacities under the statute rather than relying on Bivens; courts will then resolve those claims under the procedural and remedial rules tied to §1983 litigation (for example, fee awards under 42 U.S.C. §1988 and borrowing state statutes of limitation unless federal law directs otherwise).
The bill does not state that the United States has waived sovereign immunity; it authorizes suits against persons acting under federal authority, so the federal government itself remains protected unless other statutes apply.The bill is silent about defenses and immunities. Historically, courts developed qualified immunity and similar doctrines in the §1983 context; those doctrines have also been invoked in Bivens cases.
Because H.R. 6091 is statutory, lower courts will confront whether to apply existing qualified immunity standards unchanged, modify them, or treat statutory authorization as a reason to constrain immunity. Similarly, the statute’s expansion raises questions about interplay with the Federal Tort Claims Act, venue and removal rules, and whether indemnification practices within agencies will change.Finally, the change is narrowly drafted and deliberately minimal: it does not create new damages caps, specify remedies beyond what courts already award under §1983, or create new statutory defenses or limitations.
Implementation and the day‑to‑day consequences will therefore be driven largely by judicial interpretation, DOJ litigation practice, and agency indemnification policies rather than by additional text in the bill itself.
The Five Things You Need to Know
H.R. 6091 inserts the phrase “of the United States or” into the opening clause of the provision now codified at 42 U.S.C. §1983, bringing persons acting under federal authority within the statute’s reach.
The amendment authorizes civil damages against persons acting under color of federal law but does not amend other statutes (for example, it does not waive sovereign immunity for the United States).
Claims brought under the amended §1983 would presumptively carry the same procedural accessories as state‑actor §1983 claims—most notably attorney’s fee exposure under 42 U.S.C. §1988 and the common practice of borrowing state statutes of limitation.
The bill does not change or spell out standards for qualified immunity, damages caps, or special defenses — it leaves those issues to courts and existing precedents.
Because the change is statutory, it supplants the need to rely on the judge‑made Bivens remedy for many federal‑actor claims, but it leaves unresolved how courts will reconcile statutory authorization with existing Bivens and qualified immunity jurisprudence.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Provides the Act’s name: the “Bivens Act of 2025.” This is purely declarative and has no legal effect beyond labeling the bill; it signals congressional intent to address the remedial gap courts have navigated in Bivens litigation.
Amendment to Section 1979 (42 U.S.C. §1983): include federal authority
Makes the single operative change: it inserts the words “of the United States or” immediately before the existing phrase “of any State” in the Revised Statutes provision now codified as 42 U.S.C. §1983. That textual amendment extends the statute’s cause of action to persons who act under color of federal law. Practically, plaintiffs will be able to sue federal officers in individual capacities under the statute’s language rather than relying on Bivens; however, the amendment does not add procedural rules, limitations, or defenses, so courts will need to decide how existing §1983 doctrines apply in the federal‑actor context.
This bill is one of many.
Codify tracks hundreds of bills on Justice across all five countries.
Explore Justice in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Individuals alleging constitutional or federal‑statutory deprivations by federal actors — the statute creates a clearer, statutory path to damages remedies for detainees, arrestees, immigration‑affected persons, and others whose rights were violated by federal personnel.
- Civil rights and public‑interest litigators — a statutory cause of action improves predictability of remedies, fee shifting under §1988, and the ability to bring systemic claims against federal actors.
- Victims of federal misconduct in contexts where Bivens was previously constrained — plaintiffs who lost access to damages under recent Supreme Court narrowing of Bivens may gain a route back to court.
Who Bears the Cost
- Federal officers and employees — the practical risk of individual‑capacity suits increases the possibility of personal liability exposure and reputational costs, even if indemnification follows.
- Federal agencies and taxpayers — agencies will face higher defense and indemnification costs, potential settlements and judgments, and administrative burdens responding to more §1983 litigation targeting federal operations.
- Department of Justice — DOJ will allocate more resources to defend federal actors and may face new litigation strategies; it will also shape litigation positions on immunity and statute interpretation, affecting national litigation policy.
Key Issues
The Core Tension
The central dilemma is accountability versus operational competence: the bill advances accountability by creating a clearer statutory damages remedy for violations by federal actors, but it does so without addressing immunity doctrines, indemnification, or procedural coherence—risks that increased litigation could impair federal law‑enforcement and regulatory functions or produce uneven results across jurisdictions.
The bill’s surgical text avoids many politically charged choices while shifting a large set of practical decisions to courts and federal litigators. Because Congress did not address immunity explicitly, courts will decide whether to import the existing qualified immunity framework developed under §1983 wholesale, adapt it, or treat the statutory authorization as a reason to limit immunity.
That uncertainty will shape early litigation strategy and may produce varying outcomes across circuits. Procedural knock‑on effects are likewise unresolved: §1983 practice commonly borrows state statutes of limitation and tolling rules, but applying those borrowed rules to federal‑actor claims raises conflict‑of‑laws questions and procedural unpredictability.
Another unresolved issue is the relation to the Federal Tort Claims Act and sovereign immunity. H.R. 6091 authorizes suits against persons acting under federal authority but does not waive sovereign immunity or alter the FTCA’s distinct remedial scheme.
Plaintiffs and courts will need to sort when a claim belongs in §1983 against an individual and when FTCA or another statutory remedy is the appropriate vehicle. On the operational side, agencies will face near‑term costs and potential changes to indemnification and training priorities; those budgetary effects could feed back into agency conduct and resource allocation.
Finally, because the bill leaves damages standards and caps untouched, relief—if awarded—will be shaped by decades of §1983 remedies law, which itself is unevenly applied in federal‑actor contexts.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.